Fortrea Holdings Inc. (NASDAQ:FTRE) Receives Consensus Rating of “Hold” from Brokerages

Fortrea Holdings Inc. (NASDAQ:FTRE) has been given a consensus recommendation of “Hold” by the twelve analysts that are presently covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and four have assigned a buy rating to the company. The average 12-month target price among brokerages that have covered the stock in the last year is $16.75.

Several equities analysts have issued reports on the company. TD Cowen raised their price objective on Fortrea from $7.00 to $15.00 and gave the stock a “hold” rating in a report on Thursday, January 22nd. Mizuho set a $15.00 price target on Fortrea in a research report on Friday, January 9th. Robert W. Baird set a $19.00 target price on shares of Fortrea in a research report on Wednesday, January 14th. Evercore set a $25.00 target price on shares of Fortrea and gave the company an “outperform” rating in a report on Tuesday, January 6th. Finally, Wall Street Zen downgraded shares of Fortrea from a “buy” rating to a “hold” rating in a research report on Monday, October 27th.

Fortrea Stock Down 0.9%

Shares of NASDAQ FTRE opened at $9.70 on Wednesday. The business has a 50-day moving average of $16.01 and a two-hundred day moving average of $12.16. The company has a market capitalization of $896.28 million, a price-to-earnings ratio of -0.86, a price-to-earnings-growth ratio of 0.29 and a beta of 1.59. Fortrea has a 1 year low of $3.97 and a 1 year high of $18.67. The company has a debt-to-equity ratio of 1.81, a current ratio of 1.00 and a quick ratio of 1.00.

Institutional Trading of Fortrea

A number of institutional investors have recently bought and sold shares of FTRE. Sanctuary Advisors LLC grew its position in shares of Fortrea by 1.7% in the fourth quarter. Sanctuary Advisors LLC now owns 36,648 shares of the company’s stock valued at $632,000 after purchasing an additional 627 shares during the last quarter. Oregon Public Employees Retirement Fund boosted its stake in Fortrea by 3.4% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 21,166 shares of the company’s stock worth $365,000 after buying an additional 700 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. grew its holdings in Fortrea by 27.9% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 4,490 shares of the company’s stock valued at $77,000 after purchasing an additional 980 shares during the period. Amalgamated Bank raised its position in shares of Fortrea by 4.0% in the 3rd quarter. Amalgamated Bank now owns 26,688 shares of the company’s stock worth $225,000 after buying an additional 1,026 shares during the period. Finally, Larson Financial Group LLC lifted its stake in shares of Fortrea by 136.7% in the 4th quarter. Larson Financial Group LLC now owns 1,856 shares of the company’s stock valued at $32,000 after purchasing an additional 1,072 shares in the last quarter.

About Fortrea

Fortrea, Inc is a global contract development and manufacturing organization (CDMO) that provides integrated solutions for pharmaceutical and biotechnology companies. Established as a spin-off from Thermo Fisher Scientific’s Pharma Services business in October 2023, Fortrea leverages a legacy of scientific expertise and manufacturing scale to support drug development from early-stage research through commercial production. The company’s comprehensive offerings address the complex needs of both small-molecule and biologics programs, making it a single source for clients seeking to accelerate timelines and manage costs.

Fortrea’s core services encompass analytical and formulation development, process optimization, clinical and commercial manufacturing, and packaging services.